2 results

  • asclera

    (POLIDOCANOL)
    Methapharm, Inc
    Asclera® (polidocanol) is indicated for the sclerotherapy of uncomplicated spider veins (≤1 mm) and reticular veins (1 to 3 mm) in the lower extremities. It is not approved for use in varicose veins greater than 3 mm in diameter.

  • varithena

    (polidocanol)
    Biocompatibles, Inc.
    VARITHENA (polidocanol injectable foam) is indicated for treating incompetent great saphenous veins, accessory saphenous veins, and visible varicosities in the great saphenous vein system. It improves symptoms of superficial venous incompetence and enhances the appearance of visible varicosities.